• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Insmed Incorporated - Common Stock (NQ:INSM)

    139.52 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 10
    Open 139.52
    Bid (Size) 126.66 (100)
    Ask (Size) 149.00 (100)
    Prev. Close 139.52
    Today's Range 139.52 - 139.52
    52wk Range 60.40 - 212.75
    Shares Outstanding 115,246,666
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    The Small-Cap Renaissance: Why the Russell 2000 is Leading the Charge in 2026
    As of March 9, 2026, a dramatic regime shift is unfolding on Wall Street. After years of playing second fiddle to the "Magnificent Seven" and AI-driven mega-caps, small-cap stocks have emerged as the... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Supply Chain
    News headline image
    Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing ↗
    PTC Therapeutics develops therapies for rare diseases, with a portfolio spanning commercial products and investigational candidates. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -21.2%
    -21.2%
    1 Month
    -6.1%
    -6.1%
    3 Month
    -28.5%
    -28.5%
    6 Month
    -4.3%
    -4.3%
    1 Year
    +88.4%
    +88.4%

    More News

    Read More
    News headline image
    Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Insmed (INSM) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib ↗
    Via The Motley Fool
    Topics Stocks
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Insmed Stock Plunges Nearly 20% After Hours As Sinus Drug Fails Mid-Stage Trial And Shows No Benefit ↗
    Via Stocktwits
    News headline image
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    Via MarketMinute

    Frequently Asked Questions

    Is Insmed Incorporated - Common Stock publicly traded?
    Yes, Insmed Incorporated - Common Stock is publicly traded.
    What exchange does Insmed Incorporated - Common Stock trade on?
    Insmed Incorporated - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Insmed Incorporated - Common Stock?
    The ticker symbol for Insmed Incorporated - Common Stock is INSM on the Nasdaq Stock Market
    What is the current price of Insmed Incorporated - Common Stock?
    The current price of Insmed Incorporated - Common Stock is 139.52
    When was Insmed Incorporated - Common Stock last traded?
    The last trade of Insmed Incorporated - Common Stock was at 03/12/26 04:00 PM ET
    What is the market capitalization of Insmed Incorporated - Common Stock?
    The market capitalization of Insmed Incorporated - Common Stock is 16.08B
    How many shares of Insmed Incorporated - Common Stock are outstanding?
    Insmed Incorporated - Common Stock has 16B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.